Results 51 to 60 of about 679,279 (310)
Ezrin interacts with the SARS coronavirus spike protein and restrains infection at the entry stage [PDF]
© 2012 Millet et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are ...
Béatrice Nal +66 more
core +1 more source
COVID-19 vaccines were originally designed based on the ancestral Spike protein, but immune escape of emergent Variants of Concern (VOC) jeopardized their efficacy, warranting variant-proof vaccines.
Sabrina E. Vinzón +25 more
doaj +1 more source
Data Mining of Coronavirus: SARS-CoV-2, SARS-CoV and MERS-CoV [PDF]
Abstract Objectives: All three SARS-CoV-2, SARS-CoV and MERS-CoV belong to the Coronaviridae family. In this study we compare amino acid and codon sequence of SARS-CoV-2, SARS-CoV and MERS-CoV using different statistics programs to understand their characteristics.
Jung Eun Huh, Seunghee Han, Taeseon Yoon
openaire +4 more sources
Presentation given at Melbourne Integrative Genomics on 4/3/2020Abstract:Analysis of Sars-COV-2 direct RNA sequence dataAbstract SARS-Cov-2 (virus leading to COVID-19) transferred from an unknown animal host into humans in November 2019, and has since ...
Lachlan Coin (8249877)
core +1 more source
Amantadine Inhibits SARS-CoV-2 In Vitro [PDF]
Since the SARS-CoV-2 pandemic started in late 2019, the search for protective vaccines and for drug treatments has become mandatory to fight the global health emergency. Travel restrictions,social distancing, and face masks are suitable counter measures,
Danysz, Wojciech +11 more
core +1 more source
There are many scientific reports on the interaction of the SARS‐CoV‐2 virus S protein (and its RBD) with the human ACE2 receptor protein. However, there are no reliable data on how this interaction differs from the interaction of the receptor binding ...
Agnieszka Rombel‐Bryzek +2 more
doaj +1 more source
Prevalences of SARS-CoV-2 RNA and anti-SARS-CoV-2 positivity.
Prevalences of SARS-CoV-2 RNA and anti-SARS-CoV-2 positivity.
Woottichai Khamduang (147028) +11 more
core +1 more source
Therapeutic antibodies under development for SARS‐CoV‐2
The world is experiencing one of the most difficult moments in history with COVID‐19, which has rapidly developed into a worldwide pandemic with a significant health and economic burden.
Zetong Ma +7 more
doaj +1 more source
Guillain‐Barré syndrome after SARS‐CoV‐2 infection
We herein report a case of Guillain‐Barré syndrome (GBS) after SARS‐CoV‐2 infection. The patient was a close contact with a SARS‐CoV‐2 patient. Initially, she did not have any symptoms and quarantined at a hotel.
Mikiya Kajita +5 more
doaj +1 more source

